Plasma TIMP-1 in patients with colorectal adenomas: a prospective study
- 1 September 2004
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (14) , 2159-2164
- https://doi.org/10.1016/j.ejca.2004.06.011
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survivalEuropean Journal Of Cancer, 2004
- Tissue Inhibitor of Metalloproteinase-1 Alters the Tumorigenicity of Burkitt’s Lymphoma via Divergent Effects on Tumor Growth and AngiogenesisThe American Journal of Pathology, 2001
- In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.Journal of Clinical Investigation, 1998
- Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomasDiseases of the Colon & Rectum, 1996
- Randomised study of screening for colorectal cancer with faecal-occult-blood testThe Lancet, 1996
- Prevention of Colorectal Cancer by Colonoscopic PolypectomyNew England Journal of Medicine, 1993
- The Funen Adenoma Follow-up Study: Incidence and Death from Colorectal Carcinoma in an Adenoma Surveillance ProgramScandinavian Journal of Gastroenterology, 1993
- Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serumFEBS Letters, 1992
- Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumoursInternational Journal of Cancer, 1991
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988